Frontiers in Nutrition · 2024 · 12 citations · 104 references
AgricultureNutritionNutritional SciencesClinical NutritionHuman NutritionMicronutrient DeficiencyFat-soluble VitaminsIron NutritionLiver DiseaseMetabolic Liver DiseaseMicronutrient ToxicityNutrition In Liver DiseaseDisease Progression StagingDisease Progression VisualizationHepatic Iron AccumulationHepatocellular Carcinoma PathogenesisHistopathologic SubtypingLiver Disease - Associated DeficiencyLiver Disease ComplicationsMetabolic Dysfunction-associated Steatotic Liver Disease Fibrosis
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) has emerged as a significant global health concern, representing a major cause of liver disease worldwide. This condition spans a spectrum of histopathologic stages, beginning with simple fatty liver (MAFL), characterized by over 5% fat accumulation, and advancing to metabolic (dysfunction)-associated steatohepatitis, potentially leading to hepatocellular carcinoma. Despite extensive research, there remains a substantial gap in effective therapeutic interventions. This condition's progression is closely tied to micronutrient levels, crucial for biological functions like antioxidant activities and immune efficiency. The levels of these micronutrients exhibit considerable variability among individuals with MAFLD. Moreover, the extent of deficiency in these nutrients can vary significantly throughout the different stages of MAFLD, with disease progression potentially exacerbating these deficiencies. This review focuses on the role of micronutrients, particularly vitamins A, D, E, and minerals like iron, copper, selenium, and zinc, in MAFLD's pathophysiology. It highlights how alterations in the homeostasis of these micronutrients are intricately linked to the pathophysiological processes of MAFLD. Concurrently, this review endeavors to harness the existing evidence to propose novel therapeutic strategies targeting these vitamins and minerals in MAFLD management and offers new insights into disease mechanisms and treatment opportunities in MAFLD.
104
Tarini Shankar Ghosh, Simone Rampelli, Ian B. Jeffery et al. · Gut · 2020 · 942 citations · Full text
Vitamin D Supplementation and Prevention of Type 2 Diabetes
Anastassios G. Pittas, Bess Dawson‐Hughes, Patricia Sheehan et al. · New England Journal of Medicine · 2019 · 664 citations · Full text